Incontinence Home > VESIcare Warnings and Precautions

To help ensure a safe treatment process, it's important to review VESIcare warnings and precautions before starting the drug. For example, the drug may slow down the digestive system, increase your risk of QT prolongation, and decrease your ability to sweat. VESIcare warnings and precautions also extend to people who have glaucoma, urinary retention, or a condition that delays the emptying of food from the stomach.

VESIcare: What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking VESIcare® (solifenacin succinate) if you have:
 
  • Liver disease, including liver failure, cirrhosis, or hepatitis
  • An irregular heart rhythm (arrhythmia)
  • Kidney disease, such as kidney failure (renal failure)
  • Glaucoma
  • Digestive problems (especially problems that cause a slowing down of food through the digestive tract)
  • Difficulty passing urine
  • An enlarged prostate (also known as benign prostatic hyperplasia or BPH)
  • Any allergies, including allergies to food, dyes, or preservatives.
     
Also, let your healthcare provider know if you are:
 
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
     
Make sure to tell your healthcare provider about all other medicines you are taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.